Additional content - Extended-release methylphenidate (Concerta) for attention deficit hyperactivity disorderAdditional content - Extended-release methylphenidate (Concerta) for attention deficit hyperactivity disorder

Published 2007-02-01 00:00:00

This page contains additional content about the article Methylphenidate extended-release (Concerta) for attention deficit hyperactivity disorder (ADHD), published in NPS RADAR, April 2007.

Table 1: State/Territory authorities to contact about methylphenidate prescribing

Australian Capital Territory

ACT Department of Health & Community Care

Pharmaceutical Services, Population Health Division

Tel: 02 6207 3974 Fax: 02 6205 0997

South Australia

Public & Environmental Health Service

Department of Human Services

Tel: 08 8226 7110 Fax: 08 8226 7102

New South Wales

Pharmaceutical Services Branch

NSW Health

Tel: 02 9879 3214 Fax: 02 9859 5165

Tasmania

Pharmaceutical Services Branch

Department of Health and Human Services

Tel: 03 6233 8011 Fax: 03 6233 3904

Northern Territory

Poisons Control

Department of Health & Community Services

Tel: 08 8922 7341 Fax: 08 8922 7200

Victoria

Drugs & Poisons Unit

Department of Human Services

Tel: 1300 364 545 Fax: 1300 360 830

Queensland

Pharmaceutical Advisory Services

Queensland Health

Tel: 07 3234 1167 Fax: 07 3234 0773

Western Australia

Pharmaceutical Services Branch

Department of Health (WA)

Tel: 08 9388 4980 Fax: 08 9388 4988


Date published: 2007-02-01 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.